In 2023, the average length of stay for Crohn's Disease and Ulcerative Colitis cases in Canadian hospitals was not specified, but forecasts indicate a gradual decline in days over the coming years. From 2024 to 2028, forecasts show a year-on-year stability from 2024-2025 followed by slight annual decreases from 2026 onwards. Between 2024 and 2028, the compound annual growth rate (CAGR) reflects a minor decline, emphasizing improving patient management strategies and potentially enhanced treatment approaches.
Future trends to watch for include technological advancements in treatment and management of Crohn's Disease and Ulcerative Colitis, integration of personalized medicine, and healthcare policy changes which could impact hospital stays. Monitoring these trends will be crucial to understanding the shifts in healthcare demand and patient care efficiency.
